Status:
UNKNOWN
Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke
Lead Sponsor:
Zhejiang Hospital
Collaborating Sponsors:
Zhejiang University
Conditions:
Stroke
Eligibility:
All Genders
40-70 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of autologous peripheral hematopoietic stem cell transplantation in ischemic stroke.
Detailed Description
Stroke is among the main causes of mortality and disability of elderly population which still lack of efficient therapy. Stem sell transplantation provides a functional improvement after cerebral isch...
Eligibility Criteria
Inclusion
- aged 40\~70
- no consciousness disorders
- internal carotid artery territory infarction
- stroke happened \< 1 year
- with stable hemiplegia, but remain dependent in daily life
- SSS(Scandinavian Stroke Scale) \< 40
Exclusion
- pregnant women
- can't tolerate the test because of other disease, such as heart failure, liver failure, renal failure, abnormal blood coagulation, AIDS, combine other tumor or special condition
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01518231
Start Date
January 1 2012
End Date
December 1 2013
Last Update
January 25 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yaguo Li
Hangzhou, Zhejiang, China, 310013